Literature DB >> 938026

Susceptibility of Enterobacter to cefamandole: evidence for a high mutation rate to resistance.

C M Findell, J C Sherris.   

Abstract

Cefamandole minimum inhibitory concentrations (MICs) of 10 strains of Enterobacter were determined by the ICS agar dilution and broth dilution procedures. Agar dilution MICs ranged from 1 to 8 mug/ml, with an inoculum of 10(4) organisms/spot. Broth dilution MICs were consistently higher, with an inoculum of approximately 7 x 10(5) organisms/ml. Seven strains showed MICs of >/=64 mug/ml. There was a marked inoculum effect in broth, and skipped tubes were often observed. Variants resistant to 32 mug/ml or more were isolated by direct selection and were shown to occur at a frequency of approximately 10(-6) to 10(-7). A mutant showing a 16-fold increase in agar dilution MIC was also isolated by indirect selection. These variants and others isolated from broth in the presence of cefamandole were tested for ability to inactivate the antibiotic, using both a biological and a chemical procedure. Two distinct classes of variants were seen. Twelve of 28 were shown by both methods to inactivate the antibiotic, whereas the others, including the indirectly selected mutant, did not. The wild types were also negative by both tests. The higher cefamandole MICs of Enterobacter in broth, thus, appeared to reflect a high frequency of resistant variants that were not detected with the inoculum and end point criteria usually used in agar dilution methods. The ability of some variants to inactivate cefamandole may have resulted from a mutation that extended the activity of Enterobacter cephalosporinase to include this antibiotic.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 938026      PMCID: PMC429659          DOI: 10.1128/AAC.9.6.970

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  NATURAL AND ACQUIRED RESISTANCE OF KLEBSIELLA-AEROBACTER TO CEPHALOTHIN AND CEPHALORIDINE.

Authors:  E J BENNER; J S MICKLEWAIT; J L BRODIE; W M KIRBY
Journal:  Proc Soc Exp Biol Med       Date:  1965-06

2.  Use of cellulose acetate membranes for detecting penicillinase-producing organisms.

Authors:  R KNOX; J T SMITH
Journal:  Nature       Date:  1961-08-26       Impact factor: 49.962

3.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  Inducible beta-lactamase in Enterobacter.

Authors:  T D Hennessey
Journal:  J Gen Microbiol       Date:  1967-11

5.  Spontaneous mutant with loss of beta-lactamase in Aerobacter cloacae.

Authors:  M Goldner; D G Glass; P C Fleming
Journal:  J Bacteriol       Date:  1969-02       Impact factor: 3.490

6.  Rapid microassay of gentamicin, kanamycin, neomycin, streptomycin, and vancomycin in serum or plasma.

Authors:  L D Sabath; J I Casey; P A Ruch; L L Stumpf; M Finland
Journal:  J Lab Clin Med       Date:  1971-09

7.  Cefamandole, a cephalosporin antibiotic with an unusually wide spectrum of activity.

Authors:  H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1974-08       Impact factor: 5.191

8.  Biological properties of three 3-heterocyclic-thiomethyl cephalosporin antibiotics.

Authors:  W E Wick; D A Preston
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191

9.  Relation of beta-lactamase activity and cellular location to resistance of Enterobacter to penicillins and cephalosporins.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

10.  Antibacterial activity of cefamandole, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cephalexin.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

View more
  38 in total

1.  Cefuroxime, an in vitro Comparison with Six Other Cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Proc R Soc Med       Date:  1977

Review 2.  Resistance to third generation cephalosporins: the current situation.

Authors:  J C Pechère
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

3.  Comparison of the E test and microdilution for detection of beta-lactam-resistant mutants that are stably derepressed for type I beta-lactamase.

Authors:  C C Knapp; J A Washington
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

Review 4.  Bacterial antibiotic resistance before and after clinical application in the United States.

Authors:  A L Barry; R N Jones
Journal:  Bull N Y Acad Med       Date:  1987-04

5.  In vitro response of Enterobacter to ampicillin.

Authors:  M F Lampe; B H Minshew; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

6.  What do beta-lactamases mean for clinical efficacy?

Authors:  H C Neu
Journal:  Infection       Date:  1983       Impact factor: 3.553

7.  Cefoxitin activity against multiply antibiotic-resistance Klebsiella pneumoniae in vitro.

Authors:  R T Jackson; F E Thomas; R H Alford
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.

Authors:  C C Sanders; W E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

9.  Development of resistance to cephalosporins in clinical strains of Citrobacter spp.

Authors:  T D Gootz; D B Jackson; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

10.  Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics.

Authors:  M F Lampe; B J Allan; B H Minshew; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.